First, we analyzed the Grail expression of liver samples from with NAFLD and normal patients by immunohistochemistry and found that expression of Grail was obviously increased in fatty liver patients (Fig. 1A, B). The gene discussed is RNF128; the disease is Hepatic steatosis.